Access cutting-edge immune thrombocytopenia treatment through this clinical trial at a research site in Los Angeles. Study-provided care at no cost to qualified participants.
Access immune thrombocytopenia specialists in Los Angeles at no cost
This study follows strict safety protocols and ethical guidelines
All study-related immune thrombocytopenia treatment provided free
The purpose of this study is to evaluate the efficacy and safety of KIg 10 (Intravenous Immunoglobulin 10%) in adult patients with chronic primary ITP
Sponsor: Kedrion S.p.A.
Check if you qualify for this immune thrombocytopenia clinical trial in Los Angeles, CA
If you're searching for immune thrombocytopenia treatment options in Los Angeles, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Los Angeles research site is actively enrolling participants for this clinical trial. You'll receive care from experienced immune thrombocytopenia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.